US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

ホーム
投資
株式
アメリカ
USOTC
Biomind Labs Inc (PK) (BMNDF) 銘柄情報

Biomind Labs Inc (PK) (BMNDF)

0.12

0.00

(0.00%)

終了 6月13日 5:00AM

Biomind Labs Inc (PK) (BMNDF) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.12

( - )

買値

0.011

売値

0.39

出来高

-

0.00 日の範囲 0.00

0.011 52 週間の範囲 0.1305

時価総額

前日終値

0.12

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 2,819

発行済株式数

77,571,773

配当利回り

PER

-10.49

1 株当たり利益 (EPS)

-0.01

歳入

-

純利益

-887.75k

Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the treatment of depres... Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the treatment of depression; BMND08, a 5-Metoxi-N,N-dimethyltryptamine sublingual formulation that is in Phase II clinical trials for treatment of depression and anxiety in patients with Alzheimer’s disease; BMND06 is in Phase I clinical trial for treatment of morbid obesity; and BMDO9 is in Phase I clinical trial for treatment of Parkinson’s disease. It is also developing preclinical drug candidates, including BMND02 for the treatment of fibromyalgia; BMND03 for the treatment of addictive disorders; BMND05 to treat chronic pain; and BMND07 for the treatment of major depressive disorder. The company is headquartered in Vancouver, Canada. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.biomindlabs.com

本社

Vancouver, Canada

設立

-

Biomind Labs Inc (PK) is listed in the Healthcare sector of the その他OTC with ticker BMNDF. The last closing price for Biomind Labs (PK) was US$0.12. Over the last year, Biomind Labs (PK) shares have traded in a share price range of US$ 0.011 to US$ 0.1305.

Biomind Labs (PK) currently has 77,571,773 shares in issue. The market capitalisation of Biomind Labs (PK) is US$9.31 million. Biomind Labs (PK) has a price to earnings ratio (PE ratio) of -10.49.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0.109	990.909090909	0.011	0.1305	0.011	1728	0.07933076	CS
26	0.1042	659.493670886	0.0158	0.1305	0.011	1747	0.07951611	CS
52	0.02	20	0.1	0.1305	0.011	1328	0.08083206	CS
156	0.02	20	0.1	0.7	0.011	2722	0.25408687	CS
260	-0.659	-84.59563543	0.779	1.63	0.011	2213	0.27528355	CS

BMNDF - Frequently Asked Questions (FAQ)

What is the current Biomind Labs Inc (PK) share price?

The current share price of Biomind Labs Inc (PK) is US$ 0.12

How many Biomind Labs Inc (PK) shares are in issue?

Biomind Labs Inc (PK) has 77,571,773 shares in issue

What is the market cap of Biomind Labs Inc (PK)?

The market capitalisation of Biomind Labs Inc (PK) is USD 9.31M

What is the 1 year trading range for Biomind Labs Inc (PK) share price?

Biomind Labs Inc (PK) has traded in the range of US$ 0.011 to US$ 0.1305 during the past year

What is the PE ratio of Biomind Labs Inc (PK)?

The price to earnings ratio of Biomind Labs Inc (PK) is -10.49

What is the registered address of Biomind Labs Inc (PK)?

The registered address for Biomind Labs Inc (PK) is 515 – 701 W. Georgia Street, Vancouver, British Columbia, V7Y 1C6

What is the Biomind Labs Inc (PK) website address?

The website address for Biomind Labs Inc (PK) is www.biomindlabs.com

Which industry sector does Biomind Labs Inc (PK) operate in?

Biomind Labs Inc (PK) operates in the Biotechnology & Life Sciences sector

aredrooster

aredrooster 9分前

fmr.CEO Missling made 2 recent posts on Linkedin.

TieetCoolee

TieetCoolee 12分前

I'm sure it's just a coincidence these things began to happen shortly after F2 were made the only OTC issues available to trade through Robinhood 😜

$FMCC~ $FNMA~

grantastic

grantastic 22分前

At least the dilution stopped!

jour_trader

jour_trader 32分前

Look up a company that just had its IPO, Apotex (APTX). This site says cash flow value is $62.18 (same metric you are using for Elite’s $2.55). The IPO price was about $24. I don’t think the calculation for this metric is reliable or even close. For an IPO you are maximizing share price as the compa

skitahoe

skitahoe 34分前

Forget about the FDA for just a bit, once we have a cleanroom approved with EDEN's, then ask.
Actually, at that point you can also ask about Europe, Canada, Australia, etc. as they'll all potentially be targets for approvals.

I don't know how the company intends to build, numer

csuck555

csuck555 40分前

I might need a little help to get this to the finish line. Just give me .29 so I can start reloading and then I will let it boom. It can’t be just me playing chicken with my shares. I take the risk while someone scoops in and buys the cheapies. Not fair.

THEBEASTMUGABI

THEBEASTMUGABI 41分前

BORING !! Come on guys, what’s going on? Announce something !

csuck555

csuck555 48分前

Who’s going to help me get this to .20s next week! Let’s go!Big walls ‘a comin

surfer44

surfer44 52分前

2026 10th Capital Link Maritime Leaders Summit – Greece | Navigating the Market

https://youtu.be/CiPXZ7_tVJc

raiderz

raiderz 58分前

Wrong. 1/29/26 I’m on record:

“I’m happy to finally free up some cash and still hold a bag.”

Which is still true.

The part I embellished: price was .008 not .0085 🫡

janice shell

janice shell 1時間前

If the system just "created" a new profile for her, then why does it say the profile was created back in 2025?

Because IHub hasn't yet updated that. Go to the Message List page and scroll up to "Search this Board". You'll see that the last year available for a search is 2025. But in r

chereb19

chereb19 1時間前

You keep repeating "negative margins" as if businesses never improve economics over time. The awkward part is ignoring the obvious operational changes that affect cost structure.

The logic here seems to be: "it wasn't profitable before, therefore it can never be profitable." That's no

grantastic

grantastic 1時間前

Supposedly HDUP acquired this "LotteryHUB" in May 2022, according to their disclosure. However:

1. HDUP still listing as "acquired in the last 12 months" even as of April 2026
2. Nothing on the website "lotteryhub.com" indicates any connection to: HDUP, Mark Hutchison, Kelly

Split T

Split T 1時間前

Musk has literally guaranteed his employees a very handsome and maximum return with no chance of the stock cratering before they all dispose of what they wish to sell. SMART MOVE FOR HIM AND HIS EMPLOYEE'S . IMO they will be able to buy back in when it tanks for the first time. IT is not worth th

81vette

81vette 2時間前

I understand now,merger was complete but had a 20 day mandatory conversion waiting period from filing date ,it ended Wednesday and merger was complete and new company’s first day was Thursday,Friday was 1st day of some institutional buying (burst basket trades) Monday could be really good with insti

RockQQ

RockQQ 2時間前

Wow, we always suspected! Good link!

RockQQ

midastouch017

midastouch017 2時間前

I came to the sad conclusion that discussing
RDHL is a sheer waste of time!
:-(

MartinLutherKing

MartinLutherKing 2時間前

The short song and dance is over rockafella, You just can’t get em cheapies so easily.. You got to pay to play in the big leagues

janice shell

janice shell 2時間前

Oh yes, I remember. It's a pretty color. And they're very useful.

I may not be able to resist. It really IS a fabulous value. The reviewers seem to like it.

surfer44

surfer44 2時間前

2026 10th Capital Link Maritime Leaders Summit – Greece | Dry Bulk at an Inflection Point

https://youtu.be/adh3JnRr8qo

Whalatane

Whalatane 2時間前

My debate with Claude
Velphoro leaves 100% TDAPA reimbursement Dec 31st 2026 . OLC if approved starts 100% reimbursement ...so won't Fresenius want to switch patients to OLC especially if licensed by CSL Vifor9:44 PM

????Claude responded:
That changes the calculus mean

shajandr

shajandr 2時間前

I bought this one in 2025 and am pleased with it so far.

https://investorshub.advfn.com/uimage/uploads/2026/6/13/xfifamueller.JPG

https://www.amazon.com/dp/B0DRDNZDHK?ref=ppx_yo2ov_dt_b_fed_asin_title&th=1

BTW, when I put the bunnies' food ~OUTT under the

jour_trader

jour_trader 2時間前

lol there was no waiver. Glad you are now caught up on the real timeline.

wadegarret

wadegarret 2時間前

Valuemind- SNDK

Are you not concerned that despite only a 11-12 PE going forward, that this is a highly cyclical stock up from $30 a year ago ? I mean in other words, if judging the value of a stock today is based on future earnings going out at least 2-3 years, how can one have

Whalatane

Whalatane 2時間前

Searched the webHere's the mechanism if OLC (Renazorb) gets FDA approval and TDAPA designation:...via Claude

Normal economics without TDAPA:
Phosphate binders fall inside Medicare's ESRD bundled payment (~$281.71/treatment). Any drug a clinic uses comes out of that fixed bund

Biomind Labs (PK)

Columbus McKinnon

Srs 2 Cl A4 Res Mortgage...

International bond 0.95%...

Mulvihill Canadian Bank ...

Karmin Exploration

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。